The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...
Imagine a patient with Crohn's disease—after months of flares, they are finally in clinical remission. Their biomarkers are stable, their pain has subsided, and their doctors are satisfied. They are ...
Race for new antibiotics intensifies as WHO warns drug pipeline remains thin, and remains structurally unfit to support antibiotic innovation ...
BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP), caused by carbapenem-resistant ...
WASHINGTON, D.C. — Federal health officials announced a new partnership with leading urology organizations aimed at expanding ...
Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...
Subscribe to the Veterinary Apothecary newsletter on LinkedIn. Federal Approvals. FDA approves first and only second-generation Janus kinase inhibitor. Atinvicitinib tablets (Nume ...
After obtaining her Master’s degree in Microbiology in Barcelona, Dr. Cristina Colomer Winter began her career in industry at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results